Signalling to contractile proteins by muscarinic and purinergic pathways in neurally stimulated bladder smooth muscle
You may be a candidate if you: Meet medical eligibility for obesity/overweight or type 2 diabetes Are ready to pair medication with nutrition, movement, and sleep changes Want ongoing guidance and accountability from our clinical team We do not prescribe if there are contraindications or if it isnt clinically appropriate
The GLP-1 Compounding Shutdown: What Texas Patients and Providers Need to Know From 2022 through 2024, FDA-declared drug shortages of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) allowed 503A and 503B compounding pharmacies to legally prepare copies of these GLP-1 medications
Weight loss inevitably involves some lean mass loss, and resistance training is the most effective countermeasure
Implications for Clinical Practice These findings suggest that GLP-1 receptor agonists are not only safe from a pancreatitis risk perspective but may also confer protective effects in patients who develop acute pancreatitis